Please try another search
BioSig Technologies, Inc., together with its subsidiaries, a medical device company, engages in development and commercialization of advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with Mayo Foundation to develop an AI- and machine learning-powered software for PURE EP system. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.
Name | Age | Since | Title |
---|---|---|---|
Anthony Amato | 56 | 2021 | CEO & Director |
Frederick D. Hrkac | 58 | 2023 | President, Principal Executive Officer, Executive VP & Director |
Frank J. Quintero | 51 | 2019 | Member of Advisory Board |
Zachariah P. Zachariah | 74 | 2020 | Member of Advisory Board |
Ramachandra Malya | - | 2018 | Member of Advisory Board |
Sim Farar | 77 | 2018 | Member of Advisory Board |
Edwin J. Wang | - | 2023 | Member of Advisory Board |
Lorraine Fabiano Spurge | - | 2023 | Member of Advisory Board |
Steven E. Abelman | - | 2024 | Independent Director |
Donald F. Browne | - | 2024 | Independent Director |
Chris Baer | - | 2024 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review